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Approximately one-third of breast cancer survivors experiences persistent fatigue for months or years after successful treatment
completion. There is a lack of evidence-based treatments for cancer-related fatigue, particularly among cancer survivors. This
single-arm pilot study evaluated the feasibility and preliminary eﬃcacy of a yoga intervention for fatigued breast cancer survivors
basedontheIyengartradition.Iyengaryogaprescribesspeciﬁcposesforindividualswithspeciﬁcmedicalproblemsandconditions;
this trial emphasized postures believed to be eﬀective for reducing fatigue among breast cancer survivors, including inversions and
backbends performed with the support of props. Twelve women were enrolled in the trial, and 11 completed the full 12-week
course of treatment. There was a signiﬁcant improvement in fatigue scores from pre- to post-intervention that was maintained at
the3-monthpost-interventionfollowup.Signiﬁcantimprovementswerealsoobservedinmeasuresofphysicalfunction,depressed
mood, and quality of life. These results support the acceptability of this intervention and suggest that it may have beneﬁcial eﬀects
on persistent post-treatment fatigue. However, results require replication in a larger randomized controlled trial.
1.Introduction
Breast cancer is the most common cancer diagnosed in
females, with over 252,150 new cases expected in the United
Statesin 2008 [1]. With advancesin detection and treatment,
the number of women who survive breast cancer has
increasedsigniﬁcantlyinrecentyears.Five-yearsurvivalrates
for localized breast cancer have climbed to 98%, resulting in
an estimated 2.6 million North American women living in
the aftermath of breast cancer [1]. As survival times increase,
addressing the impact of breast cancer and its treatment
on long-term outcomes have become increasingly important
[2]. In particular, better understanding and management of
cancer-related symptoms is critical for reducing suﬀering
in cancer survivors, as highlighted by a recent State of the
Science conference sponsored by the National Institutes of
Health [3].
Fatigue is the most common and disabling symptom
among women successfully treated for breast cancer [4, 5].
Fatigue is elevated during cancer treatment [6] and persists
beyond treatment completion in a substantial minority of
women, with approximately 30% of breast cancer survivors
reporting moderate to severe symptoms of fatigue one or
more years post-treatment [7–9]. Cancer-related fatigue has
been described by patients as a “diﬀerent type of fatigue”
as it is pervasive, debilitating, and not relieved by rest,
and involves physical, mental, and emotional exhaustion
[10, 11]. Fatigue has a negative impact on work, social
relationships, and daily activities and causes signiﬁcant
impairment in overall quality of life among breast cancer
survivors [9, 12, 13]. In longitudinal assessments of breast
cancer survivors, we have found considerable stability in
fatigue levels over time. For example, fatigue scores at 1–
5 years post-diagnosis were highly correlated with fatigue
scores at 5–10 years post-diagnosis in a longitudinal study
of breast cancer survivors [14]. These ﬁndings suggest
that persistent fatigue may not remediate without targeted
treatment.2 Evidence-Based Complementary and Alternative Medicine
Despite the prevalence of cancer-related fatigue, few
evidence-based interventions are currently available to man-
age this symptom [15]. There is growing evidence that
behavioral interventions may be eﬀective in reducing fatigue
among cancer patients undergoing treatment. For example,
exercise interventions have shown positive eﬀects on fatigue
during treatment [16], as have psychosocial interventions
that include stress management and relaxation techniques
[17–19]. However, only a few behavioral intervention studies
have been conducted with cancer survivors [20], and only
one randomized trial speciﬁcally targeted survivors with
persistent fatigue [21]. Cancer survivors with persistent
fatigue may be unwilling or unable to participate in standard
exercise interventions, such as walking or cycling; indeed,
recent evidence suggests that fatigue is one of the primary
barriers to participation in exercise programs among cancer
survivors [22, 23].
Yoga is a promising alternative treatment for cancer
survivors with persistent fatigue [24]. Yoga involves physical
postures (asanas) that develop strength, ﬂexibility, and
relaxation and also promotes present awareness through the
focus on body and breath in each pose [25]. A growing
number of predominantly uncontrolled yoga intervention
trials have been conducted among patients with a variety
of medical conditions and have shown preliminary evidence
of beneﬁcial eﬀects on physical and behavioral outcomes,
including fatigue [26–28]. For example, a recent study
found that patients with multiple sclerosis randomized to an
Iyengaryogainterventionreportedsigniﬁcantimprovements
in fatigue relative to a wait-list control [29]. Yoga interven-
tions have also demonstrated positive eﬀects on behavioral
symptoms related to fatigue, including depressed mood [30–
32], pain [33–35], and physical function [36].
A growing number of yoga interventions have been
conducted with cancer patients. An early study conducted
by Cohen and colleagues found that 7 weekly sessions of
Tibetan yoga for patients with Stage I–IV lymphoma who
were receiving or had recently completed chemotherapy
led to signiﬁcant improvements in sleep quality relative
to a wait-list control, though no eﬀects on fatigue or
depression were observed [37]. This intervention included
controlled breathing and visualization and simple yoga
postures. Studies conducted with breast cancer patients and
survivors, including several recent randomized trials, have
also shown beneﬁcial eﬀects on quality of life, mood, and
fatigue [38–47]. However, none of these studies speciﬁcally
targeted patients with fatigue nor focused on fatigue as
a primary outcome. This is signiﬁcant given that fatigue
was associated with lower adherence in a recent trial of
yoga for breast cancer patients [47]. Moreover, all but one
published trial [46] has included patients who were actively
undergoing treatment. Thus, the feasibility and eﬃcacy of
yoga interventions for fatigued survivors have not been
determined.
The purpose of this pilot study was to evaluate the
acceptability of an Iyengar yoga intervention for fatigued
breast cancer survivors and to explore eﬀects on fatigue
and related outcomes. Iyengar yoga is a traditional form
of Hatha yoga based on the teachings of B.K.S. Iyengar,
a master practitioner and teacher [25, 48]. The Iyengar
yoga system focuses on the therapeutic beneﬁts of speciﬁc
postures (asanas) and breathing techniques (pranayama)t o
address speciﬁc medical problems and conditions. Iyengar-
basedyogainterventionshavebeenusedinrandomizedtrials
for multiple sclerosis [29], carpal tunnel syndrome [33],
osteoarthritis [34], lower back pain [35], and depression
[31, 32]. For each condition, a prescribed series of poses
formulated according to Mr. Iyengar’s teachings was used,
with beneﬁcial eﬀects seen on a variety of outcomes.
This study used Iyengar principles to evaluate a series
of postures and breathing techniques intended to address
symptoms of fatigue in breast cancer survivors. We focused
on Iyengar yoga because of its therapeutic orientation and
its demonstrated eﬃcacy in previous trials with medical
patients. In addition, because there is a prescribed series of
poses, Iyengar yoga is well-suited for empirical evaluation
and dissemination.
2. Methods
2.1. Participants. Breast cancer survivors with persistent
fatigue were recruited through newspapers advertisements
and ﬂyers distributed in local oncology clinics. Fatigue was
assessed with the vitality subscale of the SF-36, a reliable
and valid 4-item scale that assesses how much of the
time respondents feel “worn out”, “tired”, have “a lot of
energy”, and feel “full of pep” over the past 4 weeks [49].
Scores on this scale range from 0–100, with scores below
50 indicating disability or limitations related to fatigue.
Women who scored at or below 50 on this scale at both
a phone and an in-person screen (conducted an average
of 4 months apart) were eligible for study participation.
In previous research, we have shown that breast cancer
survivors scoring below 50 on the SF-36 show alterations
in psychosocial, immune, and neuroendocrine function,
supporting the validity of this cut-point [9, 50–54]. Other
eligibility criteria included (1) 45–65 years old, (2) originally
diagnosed with Stage 0–II breast cancer, (3) completed
local and/or adjuvant cancer therapy (with the exception
of hormonal therapy), (4) no breast cancer recurrence, (5)
no chronic medical conditions or physical contraindications
to the speciﬁc yoga sequences being taught, (e.g., immune-
related disease, diabetes, neurological disease, uncontrolled
depression, uncontrolled high blood pressure, BMI > 30,
active respiratory problems or asthma, and moderate to
severeneck,back,knee,orshoulderproblems)(6)nocurrent
yogapractice(i.e.,hadnottakenyogaclassesregularlyinpast
year), (7) nonsmoker, and (8) able to attend the scheduled
classes. These criteria were designed to control for potential
confounds that might inﬂuence fatigue levels and to ensure
participant safety.
A total of 62 women were screened by phone, 14 of
whom met initial criteria and completed an in-person screen
at UCLA. From this group, 12 were determined to be
eligible for study participation and enrolled in the trial.
Fifty women were not eligible: 8 scored above 50 on the
SF-36 vitality subscale, 6 were older than 65 years old,Evidence-Based Complementary and Alternative Medicine 3
Table 1: Demographic and medical characteristics of study partic-
ipants.
Characteristic N = 11
Age
Mean 53.8
Range 46–65
Ethnicity, no.
White 9
Nonwhite 2
Married or in signiﬁcant relationship, no.
Yes 10
No 1
Education level, no.
High school graduate 1
College graduate 4
Completed Master’s or Doctoral degree 6
Employment status, no.
Employed full or part time 9
Retired/unemployed 2
Income, no.
<$45,000 1
$45,000–$75,000 3
>$75,000 7
Type of treatment, no.
Surgery only 3
Surgery + radiation 4
Surgery + radiation + chemotherapy 4
Years since diagnosis
Mean 4.6
Range 10mo–15yrs
4 were actively receiving treatment for their breast cancer,
2 had breast cancer recurrences, 17 had chronic medical
conditions and/or injuries (including 9 with a BMI > 30),
1 was engaged in a regular yoga program, 1 was a regular
smoker, and 11 could not commit to the class schedule.
One woman withdrew from the trial after several sessions
because of a pre-existing knee condition and family-related
demands. Thus, analyses are based on the 11 women who
completed the full course of treatment. Demographic and
medical characteristics of study participants are shown in
Table 1. The mean score on the SF-36 vitality scale across
the two screening assessments was 24.3, indicating severe
fatigue. The UCLA Institutional Review Board approved
the study procedures, and written informed consent was
obtained from all participants.
2.2. Procedures. The yoga intervention was conducted in
two groups. Participants in each group were assessed before
and after the 12-week intervention and at a 3-month
post-intervention follow-up. Pre- and post-assessments were
conductedwithin1-2weeksoftheintervention,andwerenot
conducted on the same day as the yoga classes. Self-report
measures were completed at each assessment point, and
timed performance tasks were conducted at pre- and post-
intervention.Womenalsocompletedweeklydiariesassessing
fatigue and other symptoms throughout the intervention.
All 11 participants completed the pre- and post-intervention
assessments; one woman withdrew before the 3-month post-
intervention follow-upbecauseofabreastcancerrecurrence.
Recruitment materials and the study consent form indicated
that the purpose of the trial was to determine whether yoga
classes could improve energy, mood, and physical function
in breast cancer survivors.
2.3. Intervention. Iyengar yoga classes were conducted for 90
minutes twice a week for 12 weeks. This 12-week time frame
wasdesigned toaccommodatealloftheprescribed posesand
to allow suﬃcient time for beneﬁcial eﬀects on energy to
emerge. A certiﬁed Junior Intermediate Iyengar Yoga teacher
taughttheclassesundertheguidanceofanAdvancedIyengar
Yoga teacher at her home studio. The teacher was not blind
to the study design or hypotheses.
Iyengar yoga prescribes speciﬁc poses for individuals
with speciﬁc medical problems and conditions; this trial
emphasized postures believed to be eﬀective for reducing
fatigue among women with a history of breast cancer. Key
postures from the trial are listed in Table 2 and include
passive inversions (i.e., upside-down postures with support)
and passive backbends (i.e., chest opening postures with
support). In passive postures, the shape of the posture is
supported by props (e.g., blocks, bolsters, blankets, wall
ropes,andbelts),ratherthanheldbythestrengthofthebody,
so that participants can perform and maintain the postures
without stress and tension. The postures were introduced
systematically, progressing from mild to more challenging
over the course of treatment. Most poses were held from 5
to 10 minutes. Breathing techniques were taught in a supine
position with the chest supported by a bolster and the head
resting on a blanket. This position is believed to provide an
optimalopeningofthechestandlungsforbreathingwithout
strain.
Participants were not given “homework” or speciﬁcally
instructed to practice postures outside of class; this was done
toreduceparticipantburden.However,participantswerenot
discouraged from home practice, and 7 women noted that
they were practicing outside of class.
2.4. Measures. The primary outcome of interest was subjec-
tive fatigue, which was assessed using the 14-item Fatigue
Symptom Inventory (FSI) [55, 56]. The FSI assesses fatigue
intensity, duration, and interference with daily functioning.
This scale was developed for use with breast cancer patients
and has been established as a reliable and valid measure of
fatigue in cancer populations and healthy controls. The FSI
is strongly correlated with other fatigue measures, including
the fatigue scale of the POMS and the SF-36 vitality scale,
demonstrating its convergent validity. We focused on items
assessing fatigue severity and duration, including average
fatigue in last week, most fatigue in last week, and number
of days fatigued in last week.4 Evidence-Based Complementary and Alternative Medicine
Table 2: Key yoga postures for breast cancer survivors with fatigue. The following poses appear out of sequence and are not in the order in
which they were taught.
Sanskrit name Description
Supta Baddhakonasana Reclining bound angle posture
Supta Svatstikasana Reclining cross legged posture
Setubandha Sarvangasana on bolsters Bridge pose on cross bolsters
Setubandha Sarvangasana on bench Bridge pose on bench with Viparita Karani box
Purvottanasana Extension of the front body supported on two chairs
Viparita Dandasana on two chairs Backbend over two chairs with thoracic support
Salamba Sarvangasana on a chair Shoulder stand on a chair
Salamba Sirsasana on ropes Hanging rope headstand
Supta Konasana with two chairs Variation of Halasana, plow pose, with legs spread apart and feet
supported on two chairs
Viparita Karani Inverted lake pose
Bharadvajasana on chair Seated chair twist
Adhomukha Svanasana on ropes with chair Downward facing dog posture on ropes with chair
Urdhva Mukha Svanasana with chair Upward facing dog posture with chair support
Tadasana Urdhva Hastasana Mountain posture with arms stretched up
Tadasana Urdhva Baddha Hastasana Mountain posture with bound hands
Savasana Corpse posture with bolster support under chest
Secondary outcomes included depressed mood, sleep
disturbance, pain, health-related quality of life, and mea-
s u r e so fp h y s i c a lf u n c t i o n .T h eBeck Depression Inventory-
II (BDI-II) was used as a self-report measure of depressive
symptomatology [57]. This 21-item scale has excellent
reliability and validity and was associated with fatigue in
our previous research with breast cancer survivors [50]. The
Pittsburgh Sleep Quality Index (PSQI) was used to assess
subjective sleep quality [58]. This 19-item questionnaire has
been demonstrated to have high internal consistency, test-
retest reliability, and diagnostic validity. The Breast Cancer
Prevention Trial (BCPT) Symptom Scale was used to assess
general musculoskeletal pain [59]. The SF-36 was used to
assess health-related quality of life, focusing on general
health perceptions [49]. Participants also completed weekly
diaries and post-intervention interviews to evaluate their
perceptions of beneﬁt and intervention eﬃcacy.
Timed performance tasks were used to provide an
objective measure of physical function and were completed
at pre- and post-intervention. These included the 8-foot
Walk Test, a commonly used measure of functional ability
that is moderately correlated with oxygen consumption [60].
Participants were asked to walk as fast as they could for 8 feet
and the total time was measured. Timed Chair Stands were
used to assess lower extremity strength and endurance [61].
Participants were asked to stand up and sit down 5 times in
an armless, straightback chair, and their performance timed.
Forbothtasks,performancetimeswereconvertedintoscores
following standard procedures, with higher scores indicating
faster performance. Both tasks are validated measures of
physical function that can be used with middle- to older-age
individuals.
3. Results
One of the main goals of this pilot study was to evaluate
the acceptability of an Iyengar yoga intervention for breast
cancer survivors with persistent fatigue. Of the 12 women
enrolled in the trial, 11 completed the full 12-week course of
treatment, supporting the acceptability of the intervention.
The average number of classes attended was 22.4 (93% of
classes oﬀered; range = 19–24 classes attended); reasons
for missing class included illness, vacation, and travel.
At interviews conducted after treatment, all participants
reported that the intervention was beneﬁcial, that they
planned to continue with yoga, and would recommend the
intervention to other fatigued cancer survivors. At the 3-
month post-intervention follow-up, all but one participant
reported that they were continuing to take yoga classes, and
all but one (the one who had not continued with yoga)
reported that they had experienced enduring beneﬁts from
the intervention.
3.1. Improvement in Fatigue after Yoga Intervention. The
primary outcome of interest in this trial was subjective
fatigue. Paired samples t-tests showed signiﬁcant improve-
ment on the Fatigue Symptom Inventory from pre- to post-
intervention, including decreases in average fatigue (mean
change = 3.5, t(10) = 5.7, P<. 001), most fatigue (mean
change = 3.8; t(10) = 4.7, P = .001), and number of days
fatigued in last week (mean change = 2.4, t(10) = 2.9,
P<. 05), as shown in Table 3. We also saw improvements
on the vitality subscale of the SF-36, as indicated by an
increase in vitality scores (mean change = 22.7, t(10) =− 4.2,
P = .002; note that higher scores on this scale indicateEvidence-Based Complementary and Alternative Medicine 5
Table 3: Changes in fatigue and other outcomes following pilot yoga intervention.
Baseline Post-treatment 3-month follow-up
Primary outcomes: (range) Mean (SD) Mean (SD) Mean (SD)
FSI average fatigue (0–10) 6.3 (1.1) 2.7 (1.6)∗∗ 4.4 (1.8)∗∗
FSI #days fatigued (0–7) 7 (0) 4.6 (2.7)∗ 4.5 (2.2)∗∗
FSI most fatigue (0–10) 7.8 (1.3) 4.0 (2.3)∗∗ 5.8 (2.3)∗∗
SF-36 vitality scale (0–100) 27.3 (18.4) 50 (22.2)∗∗ 47.5 (18.4)∗∗
Secondary outcomes: (range) Mean (SD) Mean (SD) Mean (SD)
Depressive symptoms (BDI-II) (0–63) 15.4 (8.0) 7.5 (6.2)∗∗ 7.3 (5.6)∗∗
SF-36 general health (0–100) 50.5 (22.1) 65.0 (22.1)∗∗ 67.3 (23.9)∗∗
General pain (BCPT) (0–4) 1.5 (1.4) 0.8 (0.6) 1.3 (0.9)
Sleep quality (PSQI) (0–21) 7.1 (4.1) 6.4 (3.6) 6.0 (3.7)
Chair stand score (0–4) 2.6 (0.9) 3.5 (0.5) n/a
8-foot walk test (0–4) 3.4 (0.6) 3.4 (0.6) n/a
Paired-samples t-tests were used to evaluate diﬀerences from baseline to post-treatment and from baseline to 3-month follow-up.
∗P<. 05; ∗∗P<. 01.
more energy/less fatigue). Further, there was evidence that
these changes persisted over the 3-month post-intervention
follow-up, as changes on each measure from baseline to 3-
month post-intervention follow-up were signiﬁcant (average
fatigue: mean change = 1.9, t(9) = 3.9, P = .003; most
fatigue:meanchange=2.2,t(9) = 3.2,P = .01;daysfatigued:
meanchange =2.5,t(9) = 3.6,P = .005;SF-36vitality:mean
change = 18.5, t(9) =− 4.2, P = .002) but changes from
post-intervention to 3-month post-intervention follow-up
were not (all Ps >. 05). Analyses conducted using Wilcoxon
signed-ranked tests yielded the same results.
3.2. Improvement in Secondary Outcomes after Yoga Inter-
vention. There was a signiﬁcant decrease in depressive
symptoms on the BDI-II from pre- to post-intervention
(mean change = 7.9, t(10) = 3.3, P = .008) that persisted
at the 3-month post-intervention follow-up (mean change
= 6.7, t(9) = 3.4, P = .007). There was also signiﬁcant
improvement on the general health subscale of the SF-36
(mean change = 14.5, t(10) = 3.5, P = .005) that persisted
at the 3-month post-intervention follow-up (mean change =
14.3, t(9) = 5.1, P = .001). Changes from post-intervention
to 3-month post-intervention follow-up were not signiﬁcant
for depression or general health.
There was a trend towards a decrease in pain on the
BCPT symptom checklist from baseline to post-intervention
(P = .07), but no change from baseline to 3-month follow-
up was observed. There was no signiﬁcant change in sleep
quality on the PSQI at either assessment point (Ps >. 3).
Analyses conducted using Wilcoxon signed-ranked tests
yielded the same results. Exploratory analyses conducted on
the remaining six SF-36 subscales (physical function, role
function-physical, mental health, role function-emotional,
pain, and social function) evidenced signiﬁcant improve-
ments in role function-physical and social function (both
Ps <. 01);improvementsinsocialfunctionpersistedatthe3-
month follow-up (P<. 01). Although positive changes were
observed in all SF-36 subscales, none of the other changes
reached statistical signiﬁcance.
12-week
Iyengar yoga
program for cancer-
related fatigue
Decreased fatigue
(severity and duration)
Improved depressive
symptoms and
quality of life
(general health)
Improved physical
performance
(chair stands)
Figure 1: Demonstrates positive outcomes of a 12-week Iyengar
Yoga program for cancer-related fatigue in breast cancer survivors.
On the performance measures, there was a signiﬁ-
cant improvement in chair stands from baseline to post-
intervention (i.e., participants were able to perform signiﬁ-
cantlymorechairstandsaftertheintervention; t(10) =− 3.6,
P = .005), although no changes in the 8-foot walk test were
observed. Of note, average scores on this test approached
the scale maximum of 4 at each assessment, suggesting that
there may have been a ceiling eﬀect. Figure 1 summarizes
improvements in both primary and secondary outcomes of
interest.
3.3. Representative Comments from Study Participants. Par-
ticipants’ comments in their weekly diaries provided addi-
tional insight into their intervention experience. One partic-
ipant began to notice a change in her energy at week 3: “The
physical and mental changes are subtle, but I feel like I’m
thinking more clearly, have less brain fog, have more energy,
fatigue later rather than sooner, feel better in general, feel
stronger.” At week 10, she wrote: “I’m really aware this week
how much more energy I have to do more things in a week.
I wouldn’t describe it as “energetic,” I’d just say that I have
reserves.” Another participant summed up her experience at
week 12 as follows: “(The) eﬀects of yoga have been small6 Evidence-Based Complementary and Alternative Medicine
each week but the cumulative eﬀect has been noticeable.
I know that it is ameliorating the fatigue....T h e r e ’ sb e e n
enough progress, subtle and incremental, to believe I can get
much better.”
4. Conclusions
Results from this small, uncontrolled pilot study support the
feasibility and acceptability of a tailored Iyengar yoga inter-
vention for breast cancer survivors with persistent fatigue.
Although the women had minimal prior yoga experience,
they were enthusiastic about the classes and adherence was
excellent; indeed, almost all participants reported that they
continued taking yoga classes after the 12-week intervention
was completed, and many had purchased props so that they
couldperformposturesathome.Moreover,theywerewilling
to attempt all of the postures and reported no adverse eﬀects.
We speculate that the carefulselection of postures that would
be appropriate for this patient population, the sequencing of
postures from mild to more challenging over the course of
theintervention,thein-depthscreeningofstudyparticipants
and careful supervision throughout the trial, and instruction
by an experienced teacher all contributed to treatment
feasibility and acceptability.
Results also provide preliminary support for the eﬃcacy
of this intervention in reducing symptoms of fatigue. Scores
on each of the fatigue measures showed a signiﬁcant
improvement from pre- to post-intervention; for example,
scores on the “average fatigue” item of the FSI fell from 6.3 to
below 3, the cut-oﬀ for clinically signiﬁcant fatigue [62], and
scores on the SF-36 vitality scale increased by 22.7 points,
a clinically signiﬁcant change [63]. Further, improvements
were maintained at the 3-month post-intervention follow-
up. This can be contrasted with eﬀects seen in research
on exercise interventions for cancer survivors, which have
typically shown weaker eﬀects on subjective fatigue [64].
These ﬁndings are particularly encouraging given that study
participants had experienced fatigue for several years before
trial onset (mean number of years since diagnosis = 4.6;
range = 10 months–15 years). Of note, participants contin-
ued to score below population norms on the SF-36 vitality
scale (60.6 for women aged 45–54) at both post-treatment
assessments, suggesting that a longer intervention may be
requiredtofurtherincreaseenergylevelsamongwomenwho
have suﬀered from fatigue for many years.
Intervention eﬀects extended beyond subjective symp-
toms of fatigue to objective measures of physical perfor-
mance, speciﬁcally chair stands. These ﬁndings suggest that
the intervention may have beneﬁcial eﬀects on strength in
addition to subjective symptoms. No changes were seen in
the 8-foot walk test, although this may have been due to
the restricted range of scores on this measure. Improvements
were also seen in depressive symptoms and perceptions of
general health. At the baseline assessment, average scores
on the Beck Depression Inventory-II fell in the “mildly
depressed” range (14–19), whereas average scores at follow-
up fell in the “minimally depressed” range (0–13). On the
SF-36 general health scale, average scores fell below the
population norm of 70.5 at both assessments. Of note,
multiple statistical tests were conducted to evaluate these
secondary outcomes, increasing the risk of Type I errors.
Although these results are promising, the study has
several key limitations that render the ﬁndings preliminary.
Theﬁrstisthesmallsamplesize;only11womenparticipated
in the intervention. These women are demographically and
medically similar to a large cohort of fatigued breast cancer
survivors we have previously characterized [9], suggesting
that they may be roughly representative of this population
of women. Clearly, though, a larger sample is required to
demonstrate intervention eﬃcacy. It is also important to
note that the women in this trial were carefully screened
for medical and physical problems that might limit their
ability to safely perform the required poses; approximately
25% of the women screened for study participation were
excludedbecauseofsuchcomorbidities.Thus,thisparticular
practice may be best suited for a relatively high functioning
population. The second major limitation of this trial is the
lack of a control group. It is possible that improvements
in fatigue might have occurred in the absence of any
intervention, although our previous research indicates that
fatigue scores are quite consistent over time in women with
persistent post-treatment fatigue [14]. In addition, it is pos-
sible that nonspeciﬁc aspects of the intervention (e.g., social
support) may have inﬂuenced fatigue scores. Expectations
about treatment eﬃcacy may also have inﬂuenced outcomes;
participants were told that the intervention was designed
to increase energy, and the yoga instructor reinforced this
perspective. We are currently conducting a randomized
controlled trial of this Iyengar yoga intervention which will
provide a stronger test of its eﬃcacy and will also enable us
to test potential mechanisms for treatment eﬀects.
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